A couple of years after spinning out its active pharmaceutical ingredient (API) manufacturing business, Sanofi is now ready to list the standalone unit, called Euroapi, despite highly volatile market conditions.
In February 2020, the company set out its ambition to create a powerhouse API company by pooling the activities of six of its production sites: Brindisi (Italy), Frankfurt Chemistry (Germany), Haverhill (UK), St Aubin les Elbeuf (France), Újpest (Hungary) and Vertolaye (France)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?